5513 related articles for article (PubMed ID: 3654216)
21. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
22. [Interferon therapy in malignant melanoma].
Stadler R; Garbe C
Z Hautkr; 1990 May; 65(5):504-7. PubMed ID: 1696048
[TBL] [Abstract][Full Text] [Related]
23. Interferons. New additions and indications for use.
Stadler R; Ruszczak Z
Dermatol Clin; 1993 Jan; 11(1):187-99. PubMed ID: 7679614
[TBL] [Abstract][Full Text] [Related]
24. Interferon and interferon inactivators in patients with acquired immune deficiency syndrome and Kaposi's sarcoma. A preliminary report.
Ikossi-O'Connor MG; Ambrus JL; West T; Lillie MA; Milgrom H; Chadha KC
Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):271-7. PubMed ID: 6207572
[TBL] [Abstract][Full Text] [Related]
25. Low dose recombinant interferon alfa treatment for classic Kaposi's sarcoma.
Tur E; Brenner S; Michalevicz R
Arch Dermatol; 1993 Oct; 129(10):1297-300. PubMed ID: 8215494
[TBL] [Abstract][Full Text] [Related]
26. Combination of fibroblast interferon (HuIFN beta), carboxamide (DTIC), and cimetidine for advanced malignant melanoma.
Abdi EA; McPherson TA; Tan YH
J Biol Response Mod; 1986 Oct; 5(5):423-8. PubMed ID: 3772395
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of lymphoblastoid interferon in metastatic malignant melanoma.
Goldberg RM; Ayoob M; Silgals R; Ahlgren JD; Neefe JR
Cancer Treat Rep; 1985; 69(7-8):813-6. PubMed ID: 4016791
[TBL] [Abstract][Full Text] [Related]
28. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057.
Miles S; Levine A; Feldstein M; Carden J; Cabriallas S; Marcus S; Mitsuyasu R; Gill P
Cytokines Cell Mol Ther; 1998 Mar; 4(1):17-23. PubMed ID: 9557213
[TBL] [Abstract][Full Text] [Related]
29. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
30. Treatment of advanced, progressive epidemic Kaposi's sarcoma (EKS): a phase-II study.
Mitrou PS; Fischer C; Huhn D; Rasokat H; Ring J; Bergmann L
Onkologie; 1988 Feb; 11(1):61-2. PubMed ID: 2452394
[TBL] [Abstract][Full Text] [Related]
31. [Classical form of Kaposi sarcoma: immunology and interferon therapy].
Thiele B; Schuff-Werner P; Rahlf G; Mahrle G; Ippen H
Hautarzt; 1984 Jul; 35(7):349-53. PubMed ID: 6206024
[TBL] [Abstract][Full Text] [Related]
32. Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.
Hidalgo OF; Aramendía JM; Alonso G; Foncillas JG; Brugarolas A
Rev Med Univ Navarra; 1996; 40(3):6-12. PubMed ID: 9499820
[TBL] [Abstract][Full Text] [Related]
33. [Tolerance and feasibility of adjuvant treatment of stage II malignant melanoma with high-dose interferon-alpha].
Bédane C; Le Brun V; Boulinguez S; Berdah JF; Bouyssou ML; Delpuget N; Bernard P; Tubiana-Mathieu N; Bonnetblanc JM
Ann Dermatol Venereol; 1999 Feb; 126(2):142-6. PubMed ID: 10352829
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic trial of interferon-gamma in patients with epidemic Kaposi's sarcoma.
Krigel RL; Odajnyk CM; Laubenstein LJ; Ostreicher R; Wernz J; Vilcek J; Rubinstein P; Friedman-Kien AE
J Biol Response Mod; 1985 Aug; 4(4):358-64. PubMed ID: 3928825
[TBL] [Abstract][Full Text] [Related]
35. Treatment of in-transit metastases from cutaneous melanoma by isolation perfusion with tumour necrosis factor-alpha (TNF-alpha), melphalan and interferon-gamma (IFN-gamma). Dose-finding experience at the National Cancer Institute of Milan.
Vaglini M; Santinami M; Manzi R; Inglese MG; Santoro N; Persiani L; Belli F
Melanoma Res; 1994 Mar; 4 Suppl 1():35-8. PubMed ID: 8038594
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma in an AIDS patient.
Van Hecke E; De Bersaques J; Geerts ML
Dermatologica; 1990; 180(3):195-6. PubMed ID: 2340940
[No Abstract] [Full Text] [Related]
37. Kaposi's sarcoma in AIDS patients: long-term treatment with recombinant interferon alpha-2a and chemotherapy.
Flepp M; Täuber MG; Lüthy R; Siegenthaler W
Klin Wochenschr; 1988 May; 66(10):437-42. PubMed ID: 3135432
[TBL] [Abstract][Full Text] [Related]
38. Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial.
Krown SE; Burk MW; Kirkwood JM; Kerr D; Morton DL; Oettgen HF
Cancer Treat Rep; 1984 May; 68(5):723-6. PubMed ID: 6722830
[TBL] [Abstract][Full Text] [Related]
39. Treatment of metastatic malignant melanoma with recombinant interferon alpha 2.
Robinson WA; Mughal TI; Thomas MR; Johnson M; Spiegel RJ
Immunobiology; 1986 Sep; 172(3-5):275-82. PubMed ID: 3804370
[TBL] [Abstract][Full Text] [Related]
40. Treatments of AIDS-related Kaposi's sarcoma.
Aversa SM; Cattelan AM; Salvagno L; Crivellari G; Banna G; Trevenzoli M; Chiarion-Sileni V; Monfardini S
Crit Rev Oncol Hematol; 2005 Mar; 53(3):253-65. PubMed ID: 15718150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
